$CG

Rubenstein David M. sold $17.1M of CG

Rubenstein David M. sold 400,000 shares of Carlyle Group Inc. (CG) at $42.74 ($17.10M total) on 2026-09-11.

Original reporting
SEC EDGAR · Rubenstein David M.
Published Sep 11, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CG
Neutral
medium confidence
Mentioned
$CG
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CGNeutralLow
01

Why it matters

Traders may monitor whether this is part of a broader pattern of insider selling, but the filing alone does not change earnings power, capital allocation, or regulatory outlook.

02

Market read

A director open-market sale of about $17.1M is disclosed, which can slightly affect sentiment but is unlikely to be a standalone driver of price.

03

What to watch

No 10b5-1 plan is disclosed here, but the article also provides no reason for the sale, and the holdings after sale remain very large, reducing the inference of distress.

Relevance 7/10Novelty 4/10Timing: filed 2026-09-11, transaction dated 2026-09-11

Background

The article is an SEC Form 4 insider transaction disclosure for Carlyle Group Inc. (CG).

Company-level read

Ticker impact

$CGNeutralMedium confidence
Context

Carlyle Group director David M. Rubenstein sold 400,000 shares on 2026-09-11 at $42.74 for about $17.1M, per Form 4.

Expected impact

Likely limited near-term impact; any effect would be short-lived unless paired with broader insider selling trends or company-specific news.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no stated company event; such sales typically do not drive sustained repricing by themselves.

Market effects

Minimal. Insider sales at a single alternative-asset manager do not materially change sector fundamentals.

None indicated.

None indicated.

Counterpoint

Director sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be noise rather than bearish information.

Key entities

  • Carlyle Group Inc.

    Alternative asset manager subject of the Form 4 insider sale.

  • David M. Rubenstein

    Director who sold 400,000 shares on 2026-09-11.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CGMedAI 8/10

Carlyle Group Inc. Q2 2026: Revenue $1123.5M, EPS $0.37— 10-Q Summary

Carlyle Group Inc. reported Q2 2026 revenue of $1,123.5M and diluted EPS of $0.37, down from $1,572.9M and $0.87 in Q2 2025. Net income attributable to common stockholders fell to $137.1M from $319.7M. The company cited fee growth in management fees and a shift in fee-earning AUM toward credit and secondaries, per its Aug. 10, 2026 10-Q.

$CGMedAI 8/10

Carlyle to provide $600M to Prime Capital Financial

Carlyle’s Global Credit will provide about $600M in hybrid capital to Prime Capital Financial, including a minority stake, valuing Prime at over $1.8B enterprise value, per a press release. The deal is expected to close before Sept. 15, 2026, pending approvals. Prime manages nearly $50B in assets, and Abry exits its 2023 investment.